موضوعات مقالات

دانلود مقالات » علوم سلامت و پزشکی » داروسازی

Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant

Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
Advanced Drug Delivery Reviews
نام ژورنال: Advanced Drug Delivery Reviews
نویسنده یا نویسندگان مقاله: Annina M. Hafner , Blaise Corthesy , Hans P. Merkle
زبان: انگلیسی
سال انتشار یا تایید مقاله: 2013
شماره صفحات: 1386-1399
فرمت فایل: PDF
حجم فایل: 853 کیلوبایت
شناسه DOI:
قیمت: رایگان
   
دانلود مقاله


Current research and development of antigens for vaccination often center on purified recombinant proteins, viral subunits, synthetic oligopeptides or oligosaccharides, most of them suffering from being poorly immunogenic and subject to degradation. Hence, they call for efficient delivery systems and potent immunostimulants, jointly denoted as adjuvants. Particulate delivery systems like emulsions, liposomes, nanoparticles and microspheres may provide protection from degradation and facilitate the co-formulation of both the antigen and the immunostimulant. Synthetic double-stranded (ds) RNA, such as polyriboinosinic acid–polyribocytidylic acid, poly(I:C), is a mimic of viral dsRNA and, as such, a promising immunostimulant candidate for vaccines directed against intracellular pathogens. Poly(I:C) signaling is primarily dependent on Toll-like receptor 3 (TLR3), and on melanoma differentiation-associated gene—5 (MDA-5), and strongly drives cell-mediated immunity and a potent type I interferon response. However, stability and toxicity issues so far prevented the clinical application of dsRNAs as they undergo rapid enzymatic degradation and bear the potential to trigger undue immune stimulation as well as autoimmune disorders. This review addresses these concerns and suggests strategies to improve the safety and efficacy of immunostimulatory dsRNA formulations. The focus is on technological means required to lower the necessary dosage of poly(I:C), to target surface-modified microspheres passively or actively to antigen-presenting cells (APCs), to control their interaction with non-professional phagocytes and to modulate the resulting cytokine secretion profile.